Investors must take note of Atossa Therapeutics Inc’s (ATOS) performance last week, which was 5.85%.

On Tuesday, Atossa Therapeutics Inc (NASDAQ: ATOS) opened lower -4.22% from the last session, before settling in for the closing price of $0.98. Price fluctuations for ATOS have ranged from $0.55 to $1.71 over the past 52 weeks.

Here's Your FREE Report on the #1 Small-Cap Uranium Stock of '24.

Small-cap Uranium stocks are booming in 2024! The company we're about to show you is the ONLY small-cap stock in the space that benefits from ALL aspects of the global Uranium industry with none of the risks of running a mine. Smart investors will not be hesitating on this one!

Get the FREE Report with all the details here.


Sponsored

Company’s average yearly earnings per share was noted -21.67% at the time writing. With a float of $129.13 million, this company’s outstanding shares have now reached $129.17 million.

Let’s look at the performance matrix of the company that is accounted for 15 employees. In terms of profitability, gross margin is 0.0%, operating margin of 0.0%, and the pretax margin is 0.0%.

Atossa Therapeutics Inc (ATOS) Insider and Institutional Ownership

A key investor’s attitude towards the stock of the Biotechnology industry is another important factor to consider. The insider ownership of Atossa Therapeutics Inc is 0.03%, while institutional ownership is 26.42%. The most recent insider transaction that took place on Mar 26 ’25, was worth 7,000. In this transaction Director of this company bought 10,000 shares at a rate of $0.70, taking the stock ownership to the 10,257 shares.

Atossa Therapeutics Inc (ATOS) Latest Financial update

According to the Wall Street analysts, stocks earnings will be around -21.67% per share during the next fiscal year. For the long-term projections, market analysts anticipate that the company’s EPS will plunge by -10.52% during the next five years compared to 36.92% growth over the previous five years of trading.

Atossa Therapeutics Inc (NASDAQ: ATOS) Trading Performance Indicators

Check out the current performance indicators for Atossa Therapeutics Inc (ATOS). In the past quarter, the stock posted a quick ratio of 12.67.

For the trailing twelve months, Company’s Diluted EPS (Earnings per Share) is -0.21, a number that is poised to hit -0.06 in the next quarter and is forecasted to reach -0.27 in one year’s time.

Technical Analysis of Atossa Therapeutics Inc (ATOS)

Atossa Therapeutics Inc (NASDAQ: ATOS) saw its 5-day average volume 1.06 million, a positive change from its year-to-date volume of 0.68 million. As of the previous 9 days, the stock’s Stochastic %D was 63.89%. Additionally, its Average True Range was 0.07.

During the past 100 days, Atossa Therapeutics Inc’s (ATOS) raw stochastic average was set at 73.85%, which indicates a significant increase from 55.90% during the past two weeks. Based on volatility metrics of the stock, it showed a historical volatility of 83.47% in the past 14 days, which was higher than the 70.99% volatility it showed in the past 100 days.

At the time of writing, stock’s 50-day Moving Average is $0.7476, while its 200-day Moving Average is $1.0718. Nevertheless, the first resistance level for the watch stands at $0.9781 in the near term. At $1.0140, the stock is likely to face the second major resistance level. The third major resistance level sits at $1.0381. If the price goes on to break the first support level at $0.9181, it is likely to go to the next support level at $0.8940. The third support level lies at $0.8581 if the price breaches the second support level.

Atossa Therapeutics Inc (NASDAQ: ATOS) Key Stats

There are currently 129,170K shares outstanding in the company with a market cap of 121.69 million. Presently, the company’s annual sales total 0 K according to its annual income of -25,500 K. Last quarter, the company’s sales amounted to 0 K and its income totaled -6,720 K.

News Daemon
Privacy Overview

This website uses cookies so that we can provide you with the best user experience possible. Cookie information is stored in your browser and performs functions such as recognising you when you return to our website and helping our team to understand which sections of the website you find most interesting and useful.